William P. Mr. Burke

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Braintree, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Marc Began, as attorney-in-fact for William Burke
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for William P. Mr. Burke

Form 4 holding EVP, Chief Financial Officer

HAEMONETICS CORP

Security class
Common Stock
Shares / value
30,291
Estimated value
$2,616,839
Report date
23 Aug 2021
Price
$86.39
Ownership
Direct
Form 4 holding Chief Financial Officer

ViewRay, Inc.

Security class
Common Stock
Shares / value
356,318
Estimated value
$1,567,799
Report date
01 Mar 2023
Price
$4.40
Ownership
Direct
Form 4 holding Director

Axogen, Inc.

Security class
Restricted Stock Units
Shares / value
4,392
Estimated value
$0
Report date
24 Jun 2026
Price
$7.68
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

ViewRay, Inc.

Security class
Performance Units
Shares / value
103,686
Estimated value
Report date
01 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Axogen, Inc.

Security class
Employee Stock Option (right to purchase)
Shares / value
0
Estimated value
Report date
30 Oct 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Axogen, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
29 Oct 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Axogen, Inc.

Security class
Stock Option (right to purchase)
Shares / value
0
Estimated value
Report date
11 Nov 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Financial Officer

HAEMONETICS CORP

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
23 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William P. Mr. Burke

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .